Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 1, 2024
An Anti-CD138-Targeted Interferon-Alpha Has Broad Efficacy in Solid Tumors Through Direct Tumor Cell Killing and Intratumoral Immune Modulation
Tahmineh Safaie, Kham R Trinh, Alex Vasuthasawat, et al.
Molecular Immunology
|
July 5, 2011
In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways
Kileen L Mershon-Shier, Alex Vasuthasawat, Kazue Takahashi, et al.
Infection and Immunity
|
December 31, 2008
Role of complement in protection against Cryptococcus gattii infection
Kileen L Mershon, Alex Vasuthasawat, Gregory W Lawson, et al.
Bioengineering (Basel, Switzerland)
|
March 27, 2024
Enhancing Antibody-Specific Productivity: Unraveling the Impact of XBP1s Overexpression and Glutamine Availability in SP2/0 Cells
Priscilla González-Pereira, Ryan Trinh, Alex Vasuthasawat, et al.
Mabs
|
July 1, 2016
Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma
Alex Vasuthasawat, Esther M Yoo, Kham R Trinh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 31, 2013
Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas
Kham R Trinh, Alex Vasuthasawat, Kristopher K Steward, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
October 30, 2014
Anti-CD138-targeted interferon is a potent therapeutic against multiple myeloma
Esther M Yoo, Kham R Trinh, Danh Tran, et al.
Molecular Cancer Therapeutics
|
January 28, 2022
89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model
Kirstin A Zettlitz, Felix B Salazar, Reiko E Yamada, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
June 20, 2018
Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha
Patricia A Young, Reiko E Yamada, Kham R Trinh, et al.
Cancer Research
|
March 20, 2019
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1<sup>-</sup>HK2<sup>+</sup> Multiple Myeloma
Shili Xu, Tianyuan Zhou, Hanna M Doh, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 1, 2024
An Anti-CD138-Targeted Interferon-Alpha Has Broad Efficacy in Solid Tumors Through Direct Tumor Cell Killing and Intratumoral Immune Modulation
Tahmineh Safaie, Kham R Trinh, Alex Vasuthasawat, et al.
Molecular Immunology
|
July 5, 2011
In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways
Kileen L Mershon-Shier, Alex Vasuthasawat, Kazue Takahashi, et al.
Infection and Immunity
|
December 31, 2008
Role of complement in protection against Cryptococcus gattii infection
Kileen L Mershon, Alex Vasuthasawat, Gregory W Lawson, et al.
Bioengineering (Basel, Switzerland)
|
March 27, 2024
Enhancing Antibody-Specific Productivity: Unraveling the Impact of XBP1s Overexpression and Glutamine Availability in SP2/0 Cells
Priscilla González-Pereira, Ryan Trinh, Alex Vasuthasawat, et al.
Mabs
|
July 1, 2016
Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma
Alex Vasuthasawat, Esther M Yoo, Kham R Trinh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 31, 2013
Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas
Kham R Trinh, Alex Vasuthasawat, Kristopher K Steward, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
October 30, 2014
Anti-CD138-targeted interferon is a potent therapeutic against multiple myeloma
Esther M Yoo, Kham R Trinh, Danh Tran, et al.
Molecular Cancer Therapeutics
|
January 28, 2022
89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model
Kirstin A Zettlitz, Felix B Salazar, Reiko E Yamada, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
June 20, 2018
Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha
Patricia A Young, Reiko E Yamada, Kham R Trinh, et al.
Cancer Research
|
March 20, 2019
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1<sup>-</sup>HK2<sup>+</sup> Multiple Myeloma
Shili Xu, Tianyuan Zhou, Hanna M Doh, et al.
Page
of 1